3,4-dihydroxyphenylacetic acid has been researched along with rasagiline in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bankiewicz, KS; Finberg, JP; Goldstein, DS; Kopin, IJ; Wang, J | 1 |
| Finberg, JP; Lamensdorf, I; Youdim, MB | 1 |
| Bankiewicz, K; Finberg, JP; Goldstein, DS; Harvey-White, J; Kopin, IJ; Wang, J | 1 |
| Finberg, JP; Gross, A; Moses, D | 1 |
| Burke, WJ; Gillespie, KN; Hsu, FF; Kumar, VB; Lakshmi, VM | 1 |
5 other study(ies) available for 3,4-dihydroxyphenylacetic acid and rasagiline
| Article | Year |
|---|---|
Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clorgyline; Corpus Striatum; Dialysis; Dopamine; Homovanillic Acid; Indans; Levodopa; Male; Monoamine Oxidase Inhibitors; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selegiline; Substantia Nigra | 1995 |
Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clorgyline; Corpus Striatum; Drug Administration Schedule; Homovanillic Acid; Indans; Isoenzymes; Male; Microdialysis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selegiline; Time Factors | 1996 |
Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Corpus Striatum; Dopamine; Homovanillic Acid; Indans; Isoenzymes; Levodopa; Macaca mulatta; Microdialysis; Monoamine Oxidase; Monoamine Oxidase Inhibitors | 1998 |
Rasagiline enhances L-DOPA-induced contralateral turning in the unilateral 6-hydroxydopamine-lesioned guinea-pig.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Dopamine; Functional Laterality; Guinea Pigs; Homovanillic Acid; Indans; Male; Models, Neurological; Monoamine Oxidase Inhibitors; Motor Activity; Neuroprotective Agents; Oxidopamine; Reproducibility of Results; Substantia Nigra | 2004 |
Aldehyde adducts inhibit 3,4-dihydroxyphenylacetaldehyde-induced α-synuclein aggregation and toxicity: Implication for Parkinson neuroprotective therapy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehydes; alpha-Synuclein; Animals; Indans; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Rats | 2019 |